About FDA
Cumulative total number of email subscribers at month end (1)(3)
Targeted listserve growth is 1.4% a month.
Dictionary: Medwatch Safety Alerts: Timely new safety information on all human medical products used in patient care, including prescription and over-the-counter drugs, biologicals and vaccines, medical devices such as implants, monitors, and stents, dietary supplements, and cosmetics. These alerts contain 'actionable' information that may impact both treatment and diagnostic choices for doctor and patient.
FDA Updates for Health Professionals: Recent announcements, medical product approvals, opportunities to comment on proposed rules, upcoming public meetings, and other information of interest to health professionals.
HIV/AIDS:Source for FDA HIV/AIDS related information on a variety of topics, including product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings, proposed regulatory guidances, and opportunity to comment.
Hepatitis:Source for FDA Hepatitis related information on a variety of topics.
The more subscribers to the email listserves, the more stakeholders are being reached and being informed about the regulation of human medical products.
Fiscal Year - 2011
Targeted listserve growth is 1.4% a month.
| Time | Target | Number |
|---|---|---|
| Oct 2010 | 254,105 | 254,429 |
| Nov 2010 | 257,663 | 256,899 |
| Dec 2010 | 261,270 | 256,814 |
| Jan 2011 | 264,927 | 260,792 |
| Feb 2011 | 268,637 | 269,178 |
| Mar 2011 | 272,398 | 271,410 |
| Apr 2011 | 276,211 | 274,610 |
| May 2011 | 280,078 | 271,348 |
| Jun 2011 | 283,999 | 268,338 |
| Jul 2011 | 287,975 | 265,127 |
| Aug 2011 | 292,007 | 264,181 |
| Sep 2011 | 292,007 | 262,729 |
FY 2011 Overall: 262,729
Footnotes
- (1) Full data against all listserves was not available for October 2009.
- (2) Data was not available for October 2009.
- (3) This measure will no longer be tracked after October 2011.
Cumulative number of email subscribers to MedWatch e-list at month end
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 171,987 |
| Nov 2010 | N/A | 173,464 |
| Dec 2010 | N/A | 173,096 |
| Jan 2011 | N/A | 175,445 |
| Feb 2011 | N/A | 176,755 |
| Mar 2011 | N/A | 178,300 |
| Apr 2011 | N/A | 180,068 |
| May 2011 | N/A | 181,367 |
| Jun 2011 | N/A | 185,771 |
| Jul 2011 | N/A | 188,607 |
| Aug 2011 | N/A | 190,548 |
| Sep 2011 | N/A | 191,931 |
FY 2011 Overall: 191,931
Cumulative number of email subscribers to Health Professional Update e-list at month end
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 35,708 |
| Nov 2010 | N/A | 36,017 |
| Dec 2010 | N/A | 36,012 |
| Jan 2011 | N/A | 36,585 |
| Feb 2011 | N/A | 36,900 |
| Mar 2011 | N/A | 37,082 |
| Apr 2011 | N/A | 37,539 |
| May 2011 | N/A | 37,987 |
| Jun 2011 | N/A | 39,079 |
| Jul 2011 | N/A | 39,702 |
| Aug 2011 | N/A | 40,411 |
| Sep 2011 | N/A | 41,333 |
FY 2011 Overall: 41,333
Cumulative number of email subscribers to Hepatitis e-list at month end (2)
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 16,779 |
| Nov 2010 | N/A | 17,237 |
| Dec 2010 | N/A | 17,515 |
| Jan 2011 | N/A | 18,161 |
| Feb 2011 | N/A | 18,623 |
| Mar 2011 | N/A | 18,946 |
| Apr 2011 | N/A | 19,464 |
| May 2011 | N/A | 20,007 |
| Jun 2011 | N/A | 23,335 |
| Jul 2011 | N/A | 23,335 |
| Aug 2011 | N/A | 22,063 |
| Sep 2011 | N/A | 22,804 |
FY 2011 Overall: 22,804
Footnotes
- (2) Data was not available for October 2009.
Cumulative number of email subscribers to HIV/AIDS e-list at month end (2)
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 29,955 |
| Nov 2010 | N/A | 30,181 |
| Dec 2010 | N/A | 30,191 |
| Jan 2011 | N/A | 30,601 |
| Feb 2011 | N/A | 30,788 |
| Mar 2011 | N/A | 30,889 |
| Apr 2011 | N/A | 31,239 |
| May 2011 | N/A | 31,987 |
| Jun 2011 | N/A | 34,343 |
| Jul 2011 | N/A | 32,352 |
| Aug 2011 | N/A | 33,310 |
| Sep 2011 | N/A | 33,933 |
FY 2011 Overall: 33,933
Footnotes
- (2) Data was not available for October 2009.
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







